CVS
Price
$90.91
Change
+$2.40 (+2.71%)
Updated
Nov 3, 03:58 PM (EDT)
Capitalization
113.2B
One day until earnings call
Intraday BUY SELL Signals
XHS
Price
$141.98
Change
+$0.57 (+0.40%)
Updated
Nov 3, 04:15 PM (EDT)
Net Assets
233.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

CVS vs XHS

CVS vs XHS Comparison Chart in %
View a ticker or compare two or three
VS
CVS vs. XHS commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Hold and XHS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CVS with price predictions
Nov 02, 2026

CVS's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for CVS moved out of overbought territory on October 21, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In 23 of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVS as a result. In 52 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The Moving Average Convergence Divergence Histogram (MACD) for CVS turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 33 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.

CVS moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

CVS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for CVS crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +2.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVS advanced for three days, in 228 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 155 of 253 cases where CVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CVS's P/B Ratio (1.420) is slightly lower than the industry average of (3.345). P/E Ratio (23.170) is within average values for comparable stocks, (124.505). CVS's Projected Growth (PEG Ratio) (0.206) is slightly lower than the industry average of (0.786). CVS has a moderately high Dividend Yield (0.030) as compared to the industry average of (0.009). P/S Ratio (0.283) is also within normal values, averaging (0.569).

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating fairly steady price growth. CVS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for XHS with price predictions
Nov 02, 2026

XHS's Stochastic Oscillator is remaining in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for XHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 28 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

XHS broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on XHS as a result. In 76 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for XHS just turned positive on October 09, 2026. Looking at past instances where XHS's MACD turned positive, the stock continued to rise in 46 of 56 cases over the following month. The odds of a continued upward trend are 82%.

XHS moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XHS crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +2.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where XHS advanced for three days, in 258 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 226 of 266 cases where XHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

FUNDAMENTALS RATINGS
CVS: Fundamental Ratings
CVS
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVSXHS
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
67%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
85%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (CVS: $88.51)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVS’s FA Score shows that 1 FA rating(s) are green while .

  • CVS’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVS’s TA Score shows that 4 TA indicator(s) are bullish.

  • CVS’s TA Score: 4 bullish, 6 bearish.

Price Growth

CVS (@Managed Health Care) experienced а -4.34% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -0.68%. For the same industry, the average monthly price growth was +6.14%, and the average quarterly price growth was +21.35%.

Reported Earning Dates

CVS is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Managed Health Care (-0.68% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

View a ticker or compare two or three
CVS
Daily Signal:
Gain/Loss:
XHS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

XHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XHS has been loosely correlated with CON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if XHS jumps, then CON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XHS
1D Price
Change %
XHS100%
-1.23%
CON - XHS
56%
Loosely correlated
-0.12%
UNH - XHS
56%
Loosely correlated
-1.60%
HUM - XHS
52%
Loosely correlated
-0.99%
CVS - XHS
51%
Loosely correlated
-1.93%
CNC - XHS
47%
Loosely correlated
-2.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUPR1.840.07
+3.95%
Cuprina Holdings (Cayman) Limited
IBOC68.892.03
+3.04%
International Bancshares Corp
ECBK21.380.02
+0.09%
ECB Bancorp
AXON425.43-2.34
-0.55%
Axon Enterprise
TTI5.53-0.33
-5.63%
TETRA Technologies